Home › Compare › EMHTF vs BTI

EMHTF vs BTI: Dividend Comparison 2026

EMHTF yields 4938.27% · BTI yields 5.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMHTF wins by $55146348937607.20M in total portfolio value
10 years
EMHTF
EMHTF
● Live price
4938.27%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$55146348937607.24M
Annual income
$53,033,758,961,414,200,000.00
Full EMHTF calculator →
BTI
BTI
● Live price
5.40%
Share price
$58.26
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.8K
Annual income
$2,802.29
Full BTI calculator →

Portfolio growth — EMHTF vs BTI

📍 EMHTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMHTFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMHTF + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EMHTF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMHTF
Annual income on $10K today (after 15% tax)
$419,753.09/yr
After 10yr DRIP, annual income (after tax)
$45,078,695,117,202,070,000.00/yr
BTI
Annual income on $10K today (after 15% tax)
$459.05/yr
After 10yr DRIP, annual income (after tax)
$2,381.95/yr
At 15% tax rate, EMHTF beats the other by $45,078,695,117,202,070,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMHTF + BTI for your $10,000?

EMHTF: 50%BTI: 50%
100% BTI50/50100% EMHTF
Portfolio after 10yr
$27573174468803.64M
Annual income
$26,516,879,480,707,100,000.00/yr
Blended yield
96.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

EMHTF
Analyst Ratings
1
Hold
Consensus: Hold
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.3% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMHTF buys
0
BTI buys
0
No recent congressional trades found for EMHTF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMHTFBTI
Forward yield4938.27% ✓5.40%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3% ✓
Portfolio after 10y$55146348937607.24M ✓$37.8K
Annual income after 10y$53,033,758,961,414,200,000.00 ✓$2,802.29
Total dividends collected$55003355952995.54M ✓$14.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldBuy

Year-by-year: EMHTF vs BTI ($10,000, DRIP)

YearEMHTF PortfolioEMHTF Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$504,527$493,827.16$11,301$601.08+$493.2K → EMHTF
2$23,824,817$23,284,973.37$12,799$706.58+$23.81M → EMHTF
3$1,053,123,085$1,027,630,530.32$14,527$832.38+$1053.11M → EMHTF
4$43,579,292,978$42,452,451,277.21$16,527$982.75+$43579.28M → EMHTF
5$1,688,429,051,261$1,641,799,207,774.13$18,846$1,162.95+$1688429.03M → EMHTF
6$61,254,845,187,941$59,448,226,103,092.12$21,545$1,379.49+$61254845.17M → EMHTF
7$2,081,181,684,947,090$2,015,639,000,595,993.00$24,694$1,640.41+$2081181684.92M → EMHTF
8$66,229,598,087,621,200$64,002,733,684,727,816.00$28,378$1,955.69+$66229598087.59M → EMHTF
9$1,974,383,155,320,608,300$1,903,517,485,366,853,600.00$32,702$2,337.79+$1974383155320.58M → EMHTF
10$55,146,348,937,607,240,000$53,033,758,961,414,200,000.00$37,794$2,802.29+$55146348937607.20M → EMHTF

EMHTF vs BTI: Complete Analysis 2026

EMHTF — Stock

Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production, distribution, and sale of recreational and medical cannabis in Canada. It offers dried cannabis strains, pre-rolled cannabis, oral sprays, nano emulsion shots, and cannabis oil products under the SYNC Wellness, fuse, Emerald, and Souvenir brands. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada. As of November 10, 2022, Emerald Health Therapeutics, Inc. operates as a subsidiary of Skye Bioscience, Inc.

Full EMHTF Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this EMHTF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMHTF vs SCHDEMHTF vs JEPIEMHTF vs OEMHTF vs KOEMHTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.